ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
Clinical trial NCT05890586 · COMPLETED
Trial details
- NCT number
- NCT05890586
- Sponsor
- Susanna Naggie, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-07-04
- Enrollment
- 1331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.